Residual kidney function decline and mortality in incident hemodialysis patients

Journal of the American Society of Nephrology

Volumn 27, Issue 12, 2016, Pages 3758-3768

  Obi, Yoshitsugu ^a   Rhee, Connie M ^a   Mathew, Anna T ^b   Shah, Gaurang ^a   Streja, Elani ^a   Brunelli, Steven M ^c   Kovesdy, Csaba P ^d,e   Mehrotra, Rajnish ^f   Kalantar Zadeh, Kamyar ^a,g,h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Northwell Health   (United States)

^c DAVITA CLINICAL RESEARCH   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CALCIUM; CREATININE; FERRITIN; HEMOGLOBIN; IRON; PARATHYROID HORMONE; PHOSPHORUS; SERUM ALBUMIN; UREA;

ADULT; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; KIDNEY FUNCTION; KIDNEY PRESERVATION; LABORATORY TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RACE; RENAL CLEARANCE; RESIDUAL KIDNEY FUNCTION; ULTRAFILTRATION; UNITED STATES; UREA BLOOD LEVEL; URINE VOLUME; COMPARATIVE STUDY; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

FEMALE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 85017295766     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015101142     Document Type: Article

References (46)

1. Anonymous: Clinical practice recommendations for peritoneal dialysis adequacy. AmJ Kidney Dis 48[Suppl 1]: S130-S158, 2006
2. Hemodialysis Adequacy 2006Work Group: Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 48[Suppl 1]: S2-S90, 2006
3. Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan G: Serum beta-2 microglobulin levels predictmortality in dialysis patients: Results of theHEMOstudy.JAmSoc Nephrol 17: 546-555, 2006
4. Marquez IO, Tambra S, Luo FY, Li Y, Plummer NS, Hostetter TH, Meyer TW: Contribution of residual function to removal of protein-bound solutes in hemodialysis. Clin J Am Soc Nephrol 6: 290-296, 2011
5. Bargman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J AmSoc Nephrol 12: 2158-2162, 2001
6. Szeto CC, Wong TY, Chow KM, Leung CB, LawMC, Li PK: Independent effects of renal and peritoneal clearances on the mortality of peritoneal dialysis patients. Perit Dial Int 24: 58-64, 2004
7. Termorshuizen F, Dekker FW, vanManen JG, Korevaar JC, Boeschoten EW, Krediet RT; NECOSAD Study Group: Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: An analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 15: 1061-1070, 2004
8. Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K: Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose.NephrolDial Transplant 24: 2502-2510, 2009
9. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE: Predictors of loss of residual renal function among new dialysis patients. J AmSocNephrol 11: 556-564, 2000
10. Shafi T, Jaar BG, Plantinga LC, FinkNE, Sadler JH, Parekh RS, Powe NR, Coresh J: Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: The Choices for HealthyOutcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 56: 348-358, 2010
11. Penne EL, van der Weerd NC, Grooteman MP, Mazairac AH, van den Dorpel MA, Nubé MJ, Bots ML, Lévesque R, ter Wee PM, Blankestijn PJ; CONTRAST investigators: Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients. Clin J Am Soc Nephrol 6: 281-289, 2011
12. Mathew A, Fishbane S, Obi Y, Kalantar-Zadeh K: Preservation of residual kidney function in hemodialysis patients: Reviving an old concept for contemporary practice. Kidney Int 2016, in press
13. US Renal Data System: USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2013
14. O'Hare AM, Wong SP, Yu MK, Wynar B, Perkins M, Liu CF, Lemon JM, Hebert PL: Trends in the timing and clinical context of maintenance dialysis initiation. J Am Soc Nephrol 26: 1975-1981, 2015
15. Van Stone JC: The effect of dialyzer membrane and etiology of kidney disease on the preservation of residual renal function in chronic hemodialysis patients. ASAIO J 41: M713-M716, 1995
16. Hartmann J, Fricke H, Schiffl H: Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis. Am J Kidney Dis 30: 366-373, 1997
17. McKane W, Chandna SM, Tattersall JE, Greenwood RN, Farrington K: Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int 61: 256-265, 2002
18. Centers for Medicare & Medicaid Services (CMS), HHS: Medicare program; End-stage renal disease prospective payment system, quality incentive program, and durable medical equipment, prosthetics, orthotics, and supplies. Final rule. Fed Regist 79: 66119-66265, 2014
19. Kalantar-Zadeh K, UnruhM, Zager PG, Kovesdy CP, Bargman JM, Chen J, Sankarasubbaiyan S, Shah G, Golper T, Sherman RA, Goldfarb DS: Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis 64: 181-186, 2014
20. Obi Y, Eriguchi R, Ou SM, Rhee CM, Kalantar-Zadeh K: What is known and unknown about twice-weekly hemodialysis. Blood Purif 40: 298-305, 2015
21. Obi Y, Streja E, Rhee CM, Ravel V, Amin AN, Cupisti A, Chen J,Mathew AT, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K: Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: A cohort study [published online ahead of print February 8, 2016]. Am J Kidney Dis doi:10.1053/j.ajkd.2016.01.008
22. van derWalWM, NoordzijM, Dekker FW, Boeschoten EW, Krediet RT, Korevaar JC, Geskus RB; Netherlands Cooperative Study on the Adequacy of Dialysis Study Group (NECOSAD): Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant 26: 2978-2983, 2011
23. Lu YH, Hwang JC, JiangMY, Wang CT: Comparison of the impact of "fast decline" in residual renal function and "initial anuria" on long-term outcomes in CAPD patients. Perit Dial Int 35: 172-179, 2015
24. Itoh Y, Fujikawa T, Toya Y,MitsuhashiH,KobayashiN,Ohnishi T, Tamura K, Hirawa N, Yasuda G, Umemura S: Effect of renin-angiotensin system inhibitor on residual glomerular filtration rate in hemodialysis patients. Ther Apher Dial 16: 554-559, 2012
25. Kjaergaard KD, Peters CD, Jespersen B, Tietze IN, Madsen JK, Pedersen BB, Novosel MK, Laursen KS, Bibby BM, Strandhave C, Jensen JD: Angiotensin blockade and progressive loss of kidney function in hemodialysis patients: A randomized controlled trial. Am J Kidney Dis 64: 892-901, 2014
26. Liu S, Diao Z, Zhang D, Ding J, Cui W, Liu W: Preservation of residual renal function by not removing water in new hemodialysis patients: A randomized, controlled study. Int Urol Nephrol 46: 83-90, 2014
27. JansenMA,Hart AA, Korevaar JC,Dekker FW, Boeschoten EW, Krediet RT;NECOSAD StudyGroup: Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62: 1046-1053, 2002
28. Schiffl H, Lang SM, Fischer R: Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients. Nephrol Dial Transplant 17: 1814-1818, 2002
29. Penne EL, van der Weerd NC, van den Dorpel MA, Grooteman MP, Lévesque R, Nubé MJ, BotsML, Blankestijn PJ, terWee PM; CONTRAST Investigators: Short-termeffects of online hemodiafiltrationon phosphate control: A result from the randomized controlled Convective Transport Study (CONTRAST). Am J Kidney Dis 55: 77-87, 2010
30. Schiffl H, Lang SM, Fischer R: Effects of high efficiency post-dilution on-line hemodiafiltration or conventional hemodialysis on residual renal function and left ventricular hypertrophy. Int Urol Nephrol 45: 1389-1396, 2013
31. Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, Gillespie BW, Wizemann V, Cruz JM, Akiba T, Kurokawa K, Ramirez S, Young EW: Diuretic use, residual renal function, andmortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS). Am J Kidney Dis 49: 426-431, 2007
32. Lemes HP, Araujo S, Nascimento D, Cunha D, Garcia C, Queiroz V, Ferreira-Filho SR: Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis. Clin Exp Nephrol 15: 554-559, 2011
33. Zhang M, Wang M, Li H, Yu P, Yuan L, Hao C, Chen J, Kalantar-Zadeh K: Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients. Am J Nephrol 40: 140-150, 2014
34. Rhee CM, Unruh M, Chen J, Kovesdy CP, Zager P, Kalantar-Zadeh K: Infrequent dialysis: A new paradigm for hemodialysis initiation. Semin Dial 26: 720-727, 2013
35. Kalantar-Zadeh K, Casino FG: Let us give twice-weekly hemodialysis a chance: Revisiting the taboo. Nephrol Dial Transplant 29: 1618-1620, 2014
36. US Renal Data System: USRDS 2015 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2015
37. Mohan S, Huff E, Wish J, Lilly M, Chen SC, McClellan WM; Fistula First Breakthrough Initiative Data Committee: Recovery of renal function among ESRD patients in the US medicare program. PLoS One 8: e83447, 2013
38. Hill AB: The environment and disease: Association or causation? Proc R SocMed 58: 295-300, 1965
39. Kuttykrishnan S, Kalantar-Zadeh K, Arah OA, Cheung AK, Brunelli S, Heagerty PJ, Katz R, Molnar MZ, Nissenson A, Ravel V, Streja E, Himmelfarb J, Mehrotra R: Predictors of treatment with dialysis modalities in observational studies for comparative effectiveness research. Nephrol Dial Transplant 30: 1208-1217, 2015
40. Daugirdas JT: Physiologic Principles and Urea KineticModeling. In Handbook of Dialysis, edited by Daugirdas JT, Blake PG, Ing TS, 5th Ed., Philadelphia, Lippincott Williams & Wilkins, 2014, pp 59-60
41. Mosteller RD: Simplified calculation of body-surface area.NEnglJMed 317: 1098, 1987
42. Daugirdas JT, Leypoldt JK, Akonur A, Greene T, Depner TA; FHN Trial Group: Improved equation for estimating single-pool Kt/V at higher dialysis frequencies. Nephrol Dial Transplant 28: 2156-2160, 2013
43. Depner TA, Daugirdas JT: Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol 7: 780-785, 1996
44. Austin PC: Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28: 3083-3107, 2009
45. Schacht A, Bogaerts K, Bluhmki E, Lesaffre E: A new nonparametric approach for baseline covariate adjustment for two-group comparative studies. Biometrics 64: 1110-1116, 2008
46. Royston P, SauerbreiW, Freiburg G:Multivariable modeling with cubic regression splines: A principled approach. Stata J 7: 45-70, 2007